Association of Second-line Antidiabetic Medications With Cardiovascular Events Among Insured Adults With Type 2 Diabetes

IMPORTANCE: Understanding cardiovascular outcomes of initiating second-line antidiabetic medications (ADMs) may help inform treatment decisions after metformin alone is not sufficient or not tolerated. To date, no studies have compared the cardiovascular effects of all major second-line ADMs during...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:JAMA Netw Open
Autors principals: O’Brien, Matthew J., Karam, Susan L., Wallia, Amisha, Kang, Raymond H., Cooper, Andrew J., Lancki, Nicola, Moran, Margaret R., Liss, David T., Prospect, Theodore A., Ackermann, Ronald T.
Format: Artigo
Idioma:Inglês
Publicat: American Medical Association 2018
Matèries:
Original Investigation
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC6324353/
https://ncbi.nlm.nih.gov/pubmed/30646315
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1001/jamanetworkopen.2018.6125
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars